Leerink Partners Downgrades NeuroPace to Market Perform, Announces $7 Price Target
Leerink Partners analyst Mike Kratky downgrades NeuroPace (NASDAQ:NPCE) from Outperform to Market Perform and announces $7 price target.
Neuropace, Inc. (NPCE)
NASDAQ
$6.22
-$5.99
(-49.88%)
Regular Market
Neuropace, Inc. (NPCE) Live Price Chart
Last updated: 2026-11-13 18:01:00. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
Summary
Neuropace, Inc. (NPCE) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $6.22, with a market capitalization of $412.58M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $5.48 to $19.60. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$412.58M | |
$6.25 | |
$8.33 | |
$5.48 | |
$12.02 | |
3.36M | |
125.73K | |
-- | |
$19.60 | |
$5.48 | |
-- | |
-- |
Neuropace, Inc. (NPCE) Stock Price Today
Neuropace, Inc. (NPCE) is currently trading at $6.22 as of 2026-11-13 17:44:12, down 49.88% ($5.99) from the previous close of $12.02
During today's regular trading session, NPCE has traded between $5.48 and $8.33, with a trading volume of 3.36M shares. The current price is near the lower end of today's range.
Why Is NPCE Stock Up Today?
NPCE is up 3.99% during regular trading hours.
Neuropace shares are trading lower after the company reported mixed Q3 financial results and cut its FY26 sales guidance below estimates. Also, Leerink Partners downgraded the stock from Outperform to Market Perform and announced a $7 price target.
Neuropace, Inc. (NPCE) 7-Day Stock Price Change
Over the past seven days, Neuropace, Inc. (NPCE) moved from $12.69 to $6.22, representing a decline of 51.02% ($6.47).
The stock traded between $5.48 and $13.48 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 123.87 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
NPCE 52-Week Price Position
Position in Range: 5.2%
52W Low$5.48
52W High$19.60
NPCE is currently trading at $6.22, placing it 5.2% of the way from its 52-week low of $5.48 to its 52-week high of $19.60. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Neuropace, Inc. (NPCE)?
NeuroPace Inc is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of seizures. The company offers the RNS System, a brain-responsive neuromodulation system that continuously monitors and analyzes the brain's electrical activity and delivers personalized, real-time electrical pulses at the seizure source to prevent seizures. The RNS System includes the RNS neurostimulator, cortical strip leads, depth leads, a Patient Remote Monitor, and other implantable and non-implantable accessories used during implant procedures. The company also provides the Physician Tablet, Patient Data Management System, and the nSight Platform to facilitate ongoing patient monitoring and support clinicians in managing patient care.
Neuropace, Inc. Information
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 220 |
| Exchange | NASDAQ |
| Company Website |
NPCE News
Latest news related to Neuropace, Inc. and NPCE stock.
- BenzingaRead Full Article
- BenzingaRead Full Article
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers SELLAS Life Sciences Gr (NASDAQ:SLS) stock rose 19.6% to $9.6 during Friday's pre-market session. The market value of their outstanding shares is at $1.6 billion. As per the news, the Q3 earnings report
- BenzingaRead Full Article
NeuroPace Shares Plunge 33.61% After-Hours: Here's What Investors Should Know
NeuroPace shares tumble after-hours after missing revenue estimates and cutting 2026 sales guidance.
- MassiveRead Full Article
NeuroPace, Inc. (NPCE) Reports Q3 Loss, Misses Revenue Estimates
NeuroPace (NPCE) reported a quarterly loss of $0.03 per share, beating consensus estimates of $0.06 loss by 50%, but missed revenue expectations with $23.1 million versus the estimated $26.9 million. The company has underperformed the S&P 500 by 30.2% year-to-date. With mixed estimate revisions, the stock received a Zacks Rank #3 (Hold) rating, suggesting near-term performance in line with the market.
- BenzingaRead Full Article
NeuroPace Lowers FY2026 Sales Guidance from $99.500M-$101.500M to $91.000M-$92.000M vs $100.321M Est
NeuroPace (NASDAQ:NPCE) lowers FY2026 sales outlook from $99.500 million-$101.500 million to $91.000 million-$92.000 million vs $100.321 million estimate.
Ways to Trade NPCE at MEXC
How to Buy Neuropace, Inc. (NPCE) Stock on MEXC
Eligible investors can buy real shares of Neuropace, Inc. (NPCE) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Step 1: Open and Verify Your RealStocks Account
Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.
Step 2: Transfer USDT to Your RealStocks Account
Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.
Step 3: Search for NPCE and Place Your Order
Open the RealStocks trading page and search for NPCE. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.
Frequently Asked Questions (FAQ)
1.What is Neuropace, Inc. (NPCE) stock price today?
Neuropace, Inc. (NPCE) is currently trading at $6.22, down 49.88% ($5.99) from the previous close of $12.02. Intraday prices update in real time during regular trading hours.
2.Is NPCE stock going up or down today?
As of 2026-11-13 17:44:12, NPCE is trading at $6.22, down 49.88% ($5.99) from its previous close of $12.02. The stock has traded between $5.48 and $8.33 during today’s regular session. Past price movements do not guarantee future results.
3.What is NPCE pre-market price?
As of 2026-11-13 17:44:12, NPCE is trading at $6.36 in pre-market trading, down 47.05% ($5.66) from the previous close of $12.02. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.
4.What is NPCE after-hours price?
As of 2026-11-13 17:44:12, NPCE is trading at $7.92 in after-hours trading, up 27.33% ($1.70) from the regular-session close of $6.22. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.
5.Is NPCE stock trading now?
NPCE trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.
6.Where does NPCE sit relative to its 52-week high and low?
Over the past 52 weeks, NPCE has traded between a low of $5.48 and a high of $19.60. At $6.22, the stock is positioned 5.2% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.
7.What sector is Neuropace, Inc. in?
Neuropace, Inc. (NPCE) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.
8.What is Neuropace, Inc.'s market capitalization and where is it listed?
Neuropace, Inc. is listed on the NASDAQ exchange with a market capitalization of $412.58M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.
9.How is NPCE valued in terms of P/E ratio and EPS?
NPCE trades at a P/E ratio of --, based on trailing-twelve-month EPS of $-0.56. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.
10.Does Neuropace, Inc. pay a dividend?
Neuropace, Inc. pays an indicated annual cash dividend of $0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.
Explore More US Stocks
Largest Market Cap
See US stocks with the highest market capitalization
Most Actively Traded
Discover today's most actively traded US stocks
Top Gainers
Browse today's leading gainers in the US stock market
Top 5 Cryptocurrencies
Explore the cryptocurrencies with the highest market capitalization
Compliance Disclosure and Data Source
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to NPCE, including Stocks, Tokenized Stocks, and Stock Futures.
Disclaimer
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Search Stocks
NPCE Stock Calculator
Estimate the value between NPCE shares and USD.
NPCE Shares to USD
NPCE Shares
NPCE
USD
USD
1.00 NPCE shares = 6.216 USD
Calculations are estimates based on the latest available price and are for reference only.